Informed Consent for Use of Psychotropic Medications

Ensuring that patients are well-informed and actively involved in their treatment decisions is more important than ever, especially with the implementation of QSO-25-12-NH. The Informed

Consent for Use of Psychotropic Medication not only meets regulatory requirements but also fosters resident/representative engagement and trust.

Enhance resident engagement, ensure compliance with F605, promote a culture of informed decision-making, and strengthen your relationship with residents—all with this essential form!